Cargando…

Cost-effectiveness of scaling up of hepatitis C screening and treatment: a modelling study in South Korea

BACKGROUND: The prices and the coverage of effective direct-acting antivirals (DAAs) to treat hepatitis C vary across countries. South Korea expanded DAAs coverage through national health insurance. This study aims to analyse the cost-effectiveness of scale-up of hepatitis C screening and treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jungyeon, Haacker, Markus, Keshavjee, Salmaan, Atun, Rifat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6570985/ https://www.ncbi.nlm.nih.gov/pubmed/31263587 http://dx.doi.org/10.1136/bmjgh-2019-001441

Ejemplares similares

Trends, patterns and health consequences of multimorbidity among South Korea adults: Analysis of nationally representative survey data 2007-2016
por: Kim, Jungyeon, et al.
Publicado: (2020)

Health systems performance in managing tuberculosis: analysis of tuberculosis care cascades among high-burden and non-high-burden countries
por: Kim, Jungyeon, et al.
Publicado: (2019)

HIV and the growing health burden from noncommunicable diseases in Botswana: modelling study
por: Haacker, Markus, et al.
Publicado: (2019)

Global Financing and Long-Term Technical Assistance for Multidrug-Resistant Tuberculosis: Scaling Up Access to Treatment
por: Hwang, Thomas J., et al.
Publicado: (2014)

Effectiveness of and Financial Returns to Voluntary Medical Male Circumcision for HIV Prevention in South Africa: An Incremental Cost-Effectiveness Analysis
por: Haacker, Markus, et al.
Publicado: (2016)

Estimating the Cost-Effectiveness of One-Time Screening and Treatment for Hepatitis C in Korea
por: Kim, Do Young, et al.
Publicado: (2017)

The costs of hepatitis A infections in South Korea
por: Kim, Kyohyun, et al.
Publicado: (2014)

Scaling-up hepatitis C screening and treatment in Swiss outpatient psychiatric settings: A cost-effectiveness analysis
por: Girardin, François, et al.
Publicado: (2022)

A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective
por: Kim, Hye-Lin, et al.
Publicado: (2022)

Surgery and universal health coverage: Designing an essential package for surgical care expansion and scale-up
por: Reddy, Ché L, et al.
Publicado: (2020)

Scaling Up Towards International Targets for AIDS, Tuberculosis, and Malaria: Contribution of Global Fund-Supported Programs in 2011–2015
por: Katz, Itamar, et al.
Publicado: (2011)

Hepatitis C prevalences in the psychiatric setting: Cost-effectiveness of scaling-up screening and direct-acting antiviral therapy
por: Girardin, François, et al.
Publicado: (2021)

Clinical outcomes of remdesivir-treated COVID-19 patients in South Korea
por: Yu, Mi, et al.
Publicado: (2022)

Improving community health-care screenings with smartphone-based AI technologies
por: Mantena, Sreekar, et al.
Publicado: (2021)

Financing Essential HIV Services: A New Economic Agenda
por: Vassall, Anna, et al.
Publicado: (2013)

Contributions of declining mortality, overall and from HIV, TB and malaria, to reduced health inequality and inequity across countries
por: Haacker, Markus
Publicado: (2023)

The Cost and Cost-Effectiveness of Scaling up Screening and Treatment of Syphilis in Pregnancy: A Model
por: Kahn, James G., et al.
Publicado: (2014)

Cost-effectiveness of chronic hepatitis C screening and treatment
por: Lee, Hye Won, et al.
Publicado: (2022)

Estimation of direct medical cost related to the management of chronic hepatitis C and its complications in South Korea
por: Kim, Do Young, et al.
Publicado: (2016)

Does task shifting yield cost savings and improve efficiency for health systems? A systematic review of evidence from low-income and middle-income countries
por: Seidman, Gabriel, et al.
Publicado: (2017)

Supporting a Comprehensive International Approach to Global Tuberculosis Eradication Is the Right Thing to Do
por: Burzynski, Joseph, et al.
Publicado: (2020)

Strengthening healthcare delivery with remote patient monitoring in the time of COVID-19
por: Mantena, Sreekar, et al.
Publicado: (2021)

COVID-19 and Tuberculosis—A Global Tale of Hubris and Lessons Unlearned?
por: Drobniewski, Francis, et al.
Publicado: (2021)

Do changes to supply chains and procurement processes yield cost savings and improve availability of pharmaceuticals, vaccines or health products? A systematic review of evidence from low-income and middle-income countries
por: Seidman, Gabriel, et al.
Publicado: (2017)

The cost-effectiveness of systematic screening for age-related macular degeneration in South Korea
por: Ho, Ra, et al.
Publicado: (2018)

Viral Hepatitis in South Korea
por: C Pak, Stella, et al.
Publicado: (2017)

Current status of and strategies for hepatitis C control in South Korea
por: Kim, Beom Kyung, et al.
Publicado: (2017)

Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness
por: Nsengiyumva, Ntwali Placide, et al.
Publicado: (2022)

Double Standards in Global Health: Medicine, Human Rights Law and Multidrug-Resistant TB Treatment Policy
por: Nicholson, Thomas, et al.
Publicado: (2016)

Improved Health Outcomes from Hepatitis C Treatment Scale-Up in Spain’s Prisons: A Cost-Effectiveness Study
por: Dalgic, Ozden O., et al.
Publicado: (2019)

Cost-Effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in South Korea
por: Kang, Jung-Yoon, et al.
Publicado: (2022)

Correction: The cost-effectiveness of systematic screening for age-related macular degeneration in South Korea
por: Ra, Ho, et al.
Publicado: (2018)

Correction: The cost-effectiveness of systematic screening for age-related macular degeneration in South Korea
por: Ra, Ho, et al.
Publicado: (2018)

Current status of hepatitis C virus infection and countermeasures in South Korea
por: Jeong, Sook-Hyang, et al.
Publicado: (2017)

Healthcare Costs for Chronic Hepatitis C in South Korea from 2009 to 2013: An Analysis of the National Health Insurance Claims’ Data
por: Ki, Moran, et al.
Publicado: (2017)

Trends in cause-specific mortality in HIV–hepatitis C coinfection following hepatitis C treatment scale-up
por: Kronfli, Nadine, et al.
Publicado: (2019)

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
por: Meyer-Rath, Gesine, et al.
Publicado: (2012)

Prevalence, Awareness, and Treatment of Hepatitis C Virus Infection in South Korea: Evidence from the Korea National Health and Nutrition Examination Survey
por: Kim, Kyung-Ah, et al.
Publicado: (2020)

Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up
por: Litzroth, Amber, et al.
Publicado: (2019)

The costs of reducing loss to follow-up in South African cervical cancer screening
por: Goldhaber-Fiebert, Jeremy D, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_c8asu6moisos0g6u8mn6m3rn42